Diabetes Drug With Genetic Links Leads to Better Treatment

by Rathi Manohar on  December 27, 2010 at 7:33 PM Drug News   - G J E 4
A diabetes drug has genetic links, which when studied, could lead to new and better treatment strategies, claim scientists.

University of Dundee researchers have found how a gene known as ATM affects how well common diabetes drug metformin works in different patients.
 Diabetes Drug With Genetic Links Leads to Better Treatment
Diabetes Drug With Genetic Links Leads to Better Treatment

Dr Ewan Pearson, Professor Colin Palmer and colleagues used data from patients with diabetes and blood samples donated by 20,000 people.

Results revealed that the gene ATM and one particular chromosome determined how well patients responded to metformin.

ATM is a gene that is known to be involved in the DNA damage response system of cells, a mechanism that if faulty can lead to the development of cancer, Pearson said.

"We were expecting to find genes involved in blood sugar regulation so the finding that ATM is involved in metformin response was totally unexpected," the Scotsman quoted Pearson as saying.

"Our finding therefore draws together mechanisms that protect against cancer and lower blood sugar, suggesting a new area for diabetes drug development," he added.

Palmer agreed, "This is an important development in defining how individuals may respond differently to diabetes drugs, but further work is required before we have enough information to be able to reliably use genetic testing in the clinic to guide treatment of common forms of Type 2 diabetes."

The research was published in the journal Nature Genetics.

Source: ANI

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
Notify me when reply is posted I agree to the terms and conditions

You May Also Like